Menu
Search
|

Menu

Close
X

ICON PLC ICLR.OQ (NASDAQ Stock Exchange Global Select Market)

130.97 USD
+0.09 (+0.07%)
As of Apr 18
Previous Close 130.88
Open 131.41
Volume 61,962
3m Avg Volume 81,271
Today’s High 131.41
Today’s Low 128.70
52 Week High 154.82
52 Week Low 116.57
Shares Outstanding (mil) 53.97
Market Capitalization (mil) 7,068.67
Forward P/E 22.24
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.07 Mean rating from 15 analysts

KEY STATS

Revenue (mm, USD)
FY18
2,596
FY17
1,758
FY16
1,666
EPS (USD)
FY18
5.888
FY17
5.278
FY16
4.648
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
22.24
57.80
Price to Sales (TTM)
vs sector
2.72
9.15
Price to Book (MRQ)
vs sector
5.22
4.46
Price to Cash Flow (TTM)
vs sector
18.18
40.14
Total Debt to Equity (MRQ)
vs sector
25.79
17.00
LT Debt to Equity (MRQ)
vs sector
25.79
13.32
Return on Investment (TTM)
vs sector
19.41
11.82
Return on Equity (TTM)
vs sector
25.35
12.64

EXECUTIVE LEADERSHIP

Ciaran Murray
Chairman of the Board, Since 2017
Salary: $606,000.00
Bonus: $4,230,000.00
Steve Cutler
Chief Executive Officer, Director, Since 2017
Salary: --
Bonus: --
Brendan Brennan
Chief Financial Officer, Since 2012
Salary: $262,000.00
Bonus: $1,416,000.00
Diarmaid Cunningham
Executive Vice President, General Counsel, Secretary, Since 2014
Salary: --
Bonus: --
Hugh Brady
Non-Executive Director, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

South County Business Park, Dubl
DUBLIN     00000

Phone: +3531.2912000

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

SPONSORED STORIES